SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $29,580,000 | -21.3% | 19,300,000 | 0.0% | 2.91% | -12.2% |
Q4 2019 | $37,563,000 | +33.3% | 19,300,000 | -9.4% | 3.31% | +28.7% |
Q3 2019 | $28,175,000 | -40.6% | 21,300,000 | 0.0% | 2.57% | -30.7% |
Q2 2019 | $47,433,000 | +9.5% | 21,300,000 | -11.2% | 3.71% | -9.4% |
Q1 2019 | $43,332,000 | – | 24,000,000 | – | 4.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 55,277,000 | $84,644,000 | 4.13% |
STEELHEAD PARTNERS LLC | 19,300,000 | $29,580,000 | 2.91% |
LINDEN ADVISORS LP | 95,377,000 | $145,892,000 | 2.59% |
WOLVERINE ASSET MANAGEMENT LLC | 89,141,000 | $136,310,000 | 1.98% |
Verition Fund Management LLC | 14,735,000 | $22,403,000 | 0.88% |
ADVENT CAPITAL MANAGEMENT /DE/ | 20,376,000 | $31,177,000 | 0.68% |
Nicholas Investment Partners, LP | 1,950,000 | $2,960,000 | 0.58% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $11,527,000 | 0.56% |
SSI INVESTMENT MANAGEMENT LLC | 3,009,000 | $4,572,000 | 0.40% |
Calamos Advisors LLC | 26,471,000 | $40,570,000 | 0.32% |